Break it Down: Telix share price climbs following Citi coverage

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds.

In this episode, host Tylah Tully looks into the share price increase of big gun radiopharmaceuticals company Telix Pharmaceuticals (ASX:TLX), which surged more than 7% off the back of positive coverage from Citi Research.

Citi anticipates that Telix’s fundamental business operations will surpass market expectations and sees substantial upside in the stock. 

Watch the video to learn more.